HOME >> BIOLOGY >> NEWS
Triptolide: A potential drug for polycystic kidney disease

New Haven, Conn. A treatment for polycystic kidney disease (PKD), a leading cause of fatal kidney failure worldwide, has been identified by a research team led by Yale biochemist Craig Crews, according to a report in the Proceedings of the National Academy of Sciences.

Over 12 million people worldwide suffer from PKD, a genetic disorder that causes uncontrolled growth of cells lining tubules in the kidneys, and results in the formation of many, large fluid-filled cysts in the kidneys.

Unfortunately, aside from kidney transplantation, there has been no cure for PKD, nor has there been a suitable drug treatment to slow its progression, said Crews, associate professor of chemistry, molecular, cellular & developmental biology and pharmacology. We hope that is about to change, he said.

The mesh of Traditional Chinese Medicines (TCMs), current advances in chemistry and fundamental processes of developmental biology and health are a research focus for Crews. According to him, a roadblock in the path to TCMs as a source for new medical treatments is lack of understanding the biology and chemistry of how they work.

Triptolide is a potent, biologically active compound isolated from the medicinal Thunder God Vine Tripterygium wilfordii Hook F. The TCM tea Lei Gong Teng made from this plant has been used for centuries, as a therapeutic against cancer, inflammation, and auto-immune diseases. Crews and colleagues showed that triptolide causes cell growth arrest in certain cell types.

Normal kidney tubule cells have a built in switch for regulating their growth two proteins, PKD1 and PKD2, located on a bristle-like cilium that bends in response to fluid flow across the cell. During kidney development, cells destined to line a kidney tubule grow and divide until the tubule is fo
'"/>

Contact: Janet Rettig Emanuel
janet.emanuel@yale.edu
203-432-2157
Yale University
5-Mar-2007


Page: 1 2

Related biology news :

1. UCF research links proteins, stem cells and potential Alzheimers treatment
2. Picky eating potentially perilous for bats
3. Scientists take next step in understanding potential target for ovarian cancer treatment
4. Nanoparticles hitchhike on red blood cells: a potential new method for drug delivery
5. Weill Cornell team identifies potential new cancer drug target
6. LIAI researchers identify a potential role for retinoic acid in autoimmune and inflammatory diseases
7. GM field trials underestimate potential for cross-pollination
8. New study suggests potential for a broadly-protective HIV vaccine
9. Hamilton College researchers discover molecules with potential to treat breast cancer
10. 8 plants from South Africa may hold potential for treating high blood pressure
11. TXNIP -- regulator of glucose homeostasis and potential diabetes drug target and more

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/30/2020)... (PRWEB) , ... April 28, 2020 , ... Pebble ... world’s biggest challenges in agriculture and aquaculture with the mission of improving global food ... the 2020 F&A Next ' Next Heroes in Food- and Ag-Tech ' virtual event, ...
(Date:4/26/2020)... , ... April 23, 2020 , ... A team of ... is developing a synthetic antibody to SARS-CoV-2, the virus that causes coronavirus disease (COVID-19). ... would be another potential treatment option for COVID-19. , The efforts are being led ...
(Date:4/22/2020)... ... April 21, 2020 , ... Worcester Polytechnic Institute (WPI) is expanding an ... supplies to address the expected spike of COVID-19 cases. As part of its longtime ... for 3D printers and other materials to be sent to six countries to facilitate ...
Breaking Biology News(10 mins):
(Date:5/14/2020)... ... 13, 2020 , ... Early stages of drug discovery often ... information on the drug’s mechanism of action (MOA). Gene expression profiling technologies like ... activity of molecular pathways. This information can complement phenotypic readouts and can be ...
(Date:5/5/2020)... ... May 04, 2020 , ... ... the life sciences industry, today announced that Informa Training Partners, a life sciences ... name to Red Nucleus Boston, effective immediately. , “The name change solidifies a ...
(Date:5/5/2020)... ... May 05, 2020 , ... Smart ... launch of its iGlucose® LTE Cat-M Cellular Connected Diabetes Blood Glucose ... technology, the industry’s newest and broadest cellular connectivity available, to provide patients with ...
(Date:4/26/2020)... NEW YORK (PRWEB) , ... April 23, 2020 ... ... in the Azure Marketplace today, an online store providing applications and services for ... organizations with certain well-defined business needs to sign up online for a built-for-purpose ...
Breaking Biology Technology:
Cached News: